By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The American Civil Liberties Union and the Public Patent Foundation have petitioned the US Supreme Court to hear their case against Myriad Genetics, which seeks to invalidate patents on the BRCA1 and BRCA2 genes that are licensed by Myriad.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.